975 related articles for article (PubMed ID: 29463031)
21. Human sarcomas are mosaic for telomerase-dependent and telomerase-independent telomere maintenance mechanisms: implications for telomere-based therapies.
Gocha AR; Nuovo G; Iwenofu OH; Groden J
Am J Pathol; 2013 Jan; 182(1):41-8. PubMed ID: 23260199
[TBL] [Abstract][Full Text] [Related]
22. Alternative Lengthening of Telomeres in the Budding Yeast
Cohn M; Andersson AK; Mateo RQ; Möller MC
G3 (Bethesda); 2019 Oct; 9(10):3345-3358. PubMed ID: 31427453
[TBL] [Abstract][Full Text] [Related]
23. Coexistence of alternative lengthening of telomeres and telomerase in hTERT-transfected GM847 cells.
Perrem K; Colgin LM; Neumann AA; Yeager TR; Reddel RR
Mol Cell Biol; 2001 Jun; 21(12):3862-75. PubMed ID: 11359895
[TBL] [Abstract][Full Text] [Related]
24. Withaferin-A kills cancer cells with and without telomerase: chemical, computational and experimental evidences.
Yu Y; Katiyar SP; Sundar D; Kaul Z; Miyako E; Zhang Z; Kaul SC; Reddel RR; Wadhwa R
Cell Death Dis; 2017 Apr; 8(4):e2755. PubMed ID: 28425984
[TBL] [Abstract][Full Text] [Related]
25. Telomerase suppresses formation of ALT-associated single-stranded telomeric C-circles.
Plantinga MJ; Pascarelli KM; Merkel AS; Lazar AJ; von Mehren M; Lev D; Broccoli D
Mol Cancer Res; 2013 Jun; 11(6):557-67. PubMed ID: 23505069
[TBL] [Abstract][Full Text] [Related]
26. A human cell line that maintains telomeres in the absence of telomerase and of key markers of ALT.
Cerone MA; Autexier C; Londoño-Vallejo JA; Bacchetti S
Oncogene; 2005 Nov; 24(53):7893-901. PubMed ID: 16116482
[TBL] [Abstract][Full Text] [Related]
27. Alternative lengthening of telomeres in cancer stem cells in vivo.
Bojovic B; Booth RE; Jin Y; Zhou X; Crowe DL
Oncogene; 2015 Jan; 34(5):611-20. PubMed ID: 24531712
[TBL] [Abstract][Full Text] [Related]
28. X-rays Activate Telomeric Homologous Recombination Mediated Repair in Primary Cells.
De Vitis M; Berardinelli F; Coluzzi E; Marinaccio J; O'Sullivan RJ; Sgura A
Cells; 2019 Jul; 8(7):. PubMed ID: 31336873
[TBL] [Abstract][Full Text] [Related]
29. Repression of an alternative mechanism for lengthening of telomeres in somatic cell hybrids.
Perrem K; Bryan TM; Englezou A; Hackl T; Moy EL; Reddel RR
Oncogene; 1999 Jun; 18(22):3383-90. PubMed ID: 10362359
[TBL] [Abstract][Full Text] [Related]
30. Hyperextended telomeres promote formation of C-circle DNA in telomerase positive human cells.
Jones CY; Williams CL; Moreno SP; Morris DK; Mondello C; Karlseder J; Bertuch AA
J Biol Chem; 2023 May; 299(5):104665. PubMed ID: 37003504
[TBL] [Abstract][Full Text] [Related]
31. Disease mutant analysis identifies a new function of DAXX in telomerase regulation and telomere maintenance.
Tang M; Li Y; Zhang Y; Chen Y; Huang W; Wang D; Zaug AJ; Liu D; Zhao Y; Cech TR; Ma W; Songyang Z
J Cell Sci; 2015 Jan; 128(2):331-41. PubMed ID: 25416818
[TBL] [Abstract][Full Text] [Related]
32. Telomeres and telomerase in sarcomas.
Matsuo T; Shimose S; Kubo T; Fujimori J; Yasunaga Y; Ochi M
Anticancer Res; 2009 Oct; 29(10):3833-6. PubMed ID: 19846916
[TBL] [Abstract][Full Text] [Related]
33. Functional Loss of
Graham MK; Kim J; Da J; Brosnan-Cashman JA; Rizzo A; Baena Del Valle JA; Chia L; Rubenstein M; Davis C; Zheng Q; Cope L; Considine M; Haffner MC; De Marzo AM; Meeker AK; Heaphy CM
Mol Cancer Res; 2019 Dec; 17(12):2480-2491. PubMed ID: 31611308
[TBL] [Abstract][Full Text] [Related]
34. Evidence for alternative lengthening of telomeres in liposarcomas in the absence of ALT-associated PML bodies.
Jeyapalan JN; Mendez-Bermudez A; Zaffaroni N; Dubrova YE; Royle NJ
Int J Cancer; 2008 Jun; 122(11):2414-21. PubMed ID: 18311780
[TBL] [Abstract][Full Text] [Related]
35. Switch telomerase to ALT mechanism by inducing telomeric DNA damages and dysfunction of ATRX and DAXX.
Hu Y; Shi G; Zhang L; Li F; Jiang Y; Jiang S; Ma W; Zhao Y; Songyang Z; Huang J
Sci Rep; 2016 Aug; 6():32280. PubMed ID: 27578458
[TBL] [Abstract][Full Text] [Related]
36. Diagnosis and treatment of ALT tumors: is Trabectedin a new therapeutic option?
Pompili L; Leonetti C; Biroccio A; Salvati E
J Exp Clin Cancer Res; 2017 Dec; 36(1):189. PubMed ID: 29273061
[TBL] [Abstract][Full Text] [Related]
37. Divergent patterns of telomere maintenance mechanisms among human sarcomas: sharply contrasting prevalence of the alternative lengthening of telomeres mechanism in Ewing's sarcomas and osteosarcomas.
Ulaner GA; Hoffman AR; Otero J; Huang HY; Zhao Z; Mazumdar M; Gorlick R; Meyers P; Healey JH; Ladanyi M
Genes Chromosomes Cancer; 2004 Oct; 41(2):155-62. PubMed ID: 15287028
[TBL] [Abstract][Full Text] [Related]
38. Different telomere maintenance mechanisms in alveolar and embryonal rhabdomyosarcoma.
Ohali A; Avigad S; Naumov I; Goshen Y; Ash S; Yaniv I
Genes Chromosomes Cancer; 2008 Nov; 47(11):965-70. PubMed ID: 18663749
[TBL] [Abstract][Full Text] [Related]
39. Alternative lengthening of telomeres in mammalian cells.
Henson JD; Neumann AA; Yeager TR; Reddel RR
Oncogene; 2002 Jan; 21(4):598-610. PubMed ID: 11850785
[TBL] [Abstract][Full Text] [Related]
40. TCGA Pan-Cancer Genomic Analysis of Alternative Lengthening of Telomeres (ALT) Related Genes.
Armendáriz-Castillo I; López-Cortés A; García-Cárdenas J; Guevara-Ramírez P; Leone PE; Pérez-Villa A; Yumiceba V; Zambrano AK; Guerrero S; Paz-Y-Miño C
Genes (Basel); 2020 Jul; 11(7):. PubMed ID: 32708340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]